209 related articles for article (PubMed ID: 12898190)
21. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
Kingsmore SF; Silva OE; Hall BD; Sheldon EA; Cripe LD; St Clair EW
J Rheumatol; 1993 Sep; 20(9):1588-91. PubMed ID: 8164221
[TBL] [Abstract][Full Text] [Related]
22. Diffuse large B-cell lymphoma arising from a multicentric mixed variant of Castleman's disease.
Venizelos I; Tamiolakis D; Simopoulos C; Nikolaidou S; Barbagadaki S; Lambropoulou M; Alexiadis G; Boglou P; Papadopoulos N
Indian J Cancer; 2004; 41(3):135-7. PubMed ID: 15472414
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
[TBL] [Abstract][Full Text] [Related]
24. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study.
Guihot A; Couderc LJ; Agbalika F; Galicier L; Bossi P; Rivaud E; Scherrer A; Zucman D; Katlama C; Oksenhendler E
Eur Respir J; 2005 Jul; 26(1):118-25. PubMed ID: 15994398
[TBL] [Abstract][Full Text] [Related]
26. Castleman's disease and HIV infection in Australia.
Loi S; Goldstein D; Clezy K; Milliken ST; Hoy J; Chipman M
HIV Med; 2004 May; 5(3):157-62. PubMed ID: 15139981
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report.
Johns RH; Doyle T; Lipman MC; Cwynarski K; Cleverley JR; Isaacson PG; Shaw S; Agarwal B
J Med Case Rep; 2010 Jan; 4():32. PubMed ID: 20205844
[TBL] [Abstract][Full Text] [Related]
28. Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.
De Marchi G; De Vita S; Fabris M; Scott CA; Ferraccioli G
Haematologica; 2004 Apr; 89(4):ECR03. PubMed ID: 15075095
[TBL] [Abstract][Full Text] [Related]
29. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
30. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.
Derici U; Arinsoy T; Ataoglu O; Bali M; Eroglu A; Goker B; Sindel S
Ann Hematol; 2002 Jul; 81(7):399-401. PubMed ID: 12185513
[TBL] [Abstract][Full Text] [Related]
31. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
[TBL] [Abstract][Full Text] [Related]
32. Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.
Kotb R; Vincent I; Dulioust A; Peretti D; Taburet AM; Delfraissy JF; Goujard C
Eur J Haematol; 2006 Mar; 76(3):269-71. PubMed ID: 16451402
[TBL] [Abstract][Full Text] [Related]
33. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
[TBL] [Abstract][Full Text] [Related]
34. Multicentric Castleman's disease complicated by secondary renal amyloidosis.
Leung KT; Wong KM; Choi KS; Chau KF; Li CS
Nephrology (Carlton); 2004 Dec; 9(6):392-3. PubMed ID: 15663642
[No Abstract] [Full Text] [Related]
35. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
Peker D; Martinez AE; Schwartz MA; Cusnir M
Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
[No Abstract] [Full Text] [Related]
36. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
37. Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy.
Műzes G; Sipos F; Csomor J; Sréter L
APMIS; 2013 Jul; 121(7):668-74. PubMed ID: 23163599
[TBL] [Abstract][Full Text] [Related]
38. Human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient presenting with relapsing and remitting hyponatraemia.
Sasaki H; Maeda T; Hara Y; Osa M; Imai K; Moriguchi K; Mikita K; Fujikura Y; Kaida K; Kawana A
Int J STD AIDS; 2015 Oct; 26(12):909-11. PubMed ID: 25504830
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.
Kumari P; Schechter GP; Saini N; Benator DA
Clin Infect Dis; 2000 Aug; 31(2):602-4. PubMed ID: 10987728
[TBL] [Abstract][Full Text] [Related]
40. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
